International Clinical Trial: To investigate the efficacy and safety of irinotecan liposome combined with fluorouracil and oxaliplatin as neoadjuvant therapy for locally advanced rectal cancer

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117281) titled 'To investigate the efficacy and safety of irinotecan liposome combined with fluorouracil and oxaliplatin as neoadjuvant therapy for locally advanced rectal cancer' on Jan. 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Tianjin Medical University General Hospital

Condition: Locally advanced rectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-22

Target Sample Size: Experimental group:34;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300143

Disclaimer: Curated by HT Syndication....